Keyword Connections

metastatic prostate cancer

Journals

4

1 Gene

2 Journal of geriatric oncology

3 JAAPA

4 The patient

Research Groups

0

No Research Group Connected

Bibliographies

16

1 Upregulation of potential regulatory signaling molecules correlate with androgen receptor splice variants AR-V7 and AR-V567es in prostate cancer metastasis.

2 Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort.

3 Oral iron replacement vs. IV iron treatment in bariatric surgery patients with anemia.

4 Correction to: How Does the Public Evaluate Vaccines for Low‑Incidence, Severe‑Outcome Diseases? A General‑Population Choice Experiment.

5 How Does the Public Evaluate Vaccines for Low-Incidence, Severe-Outcome Diseases? A General-Population Choice Experiment.

6 SCORT-Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo.

7 Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer

8 Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer.

9 Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?

10 Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer

11 metastatic prostate cancer with elevated serum levels of cea and ca19-9

12 the igr-cap1 xenograft model recapitulates mixed osteolytic/blastic bone lesions observed in metastatic prostate cancer

13 prostatectomy for metastatic prostate cancer: a clinical case

14 integrating circulating tumor cell data with imaging and serum prostate-specific antigen measurement for metastatic prostate cancer therapy management

15 severe hypocalcemia due to denosumab in metastatic prostate cancer

16 Global Disparity in Access to Novel Therapeutics for Metastatic Prostate Cancer.